Varian Medical Systems, Inc. (VAR) Director R Andrew Eckert Sells 5,651 Shares

Varian Medical Systems, Inc. (NYSE:VAR) Director R Andrew Eckert sold 5,651 shares of Varian Medical Systems stock in a transaction on Friday, October 6th. The shares were sold at an average price of $102.39, for a total transaction of $578,605.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of Varian Medical Systems, Inc. (NYSE:VAR) opened at 104.20 on Wednesday. The company has a market cap of $9.57 billion, a price-to-earnings ratio of 34.30 and a beta of 0.56. The company’s 50-day moving average is $103.97 and its 200-day moving average is $99.49. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.87.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The business had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. During the same quarter in the previous year, the company posted $1.00 EPS. The business’s revenue was up 3.0% on a year-over-year basis. On average, equities analysts predict that Varian Medical Systems, Inc. will post $3.93 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by BBNS and is owned by of BBNS. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/varian-medical-systems-inc-var-director-sells-578605-89-in-stock/1701286.html.

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Varian Medical Systems by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock worth $944,980,000 after purchasing an additional 150,482 shares during the period. BlackRock Inc. grew its holdings in shares of Varian Medical Systems by 6.6% during the 2nd quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock worth $869,233,000 after purchasing an additional 523,858 shares during the period. First Eagle Investment Management LLC grew its holdings in shares of Varian Medical Systems by 0.8% during the 2nd quarter. First Eagle Investment Management LLC now owns 4,679,471 shares of the medical equipment provider’s stock worth $482,875,000 after purchasing an additional 38,005 shares during the period. State Street Corp grew its holdings in shares of Varian Medical Systems by 1.3% during the 1st quarter. State Street Corp now owns 4,324,762 shares of the medical equipment provider’s stock worth $394,109,000 after purchasing an additional 57,090 shares during the period. Finally, Janus Capital Management LLC grew its holdings in shares of Varian Medical Systems by 8.5% during the 1st quarter. Janus Capital Management LLC now owns 3,932,124 shares of the medical equipment provider’s stock worth $358,332,000 after purchasing an additional 306,975 shares during the period. Institutional investors and hedge funds own 99.24% of the company’s stock.

VAR has been the subject of a number of recent research reports. BidaskClub cut shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 29th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 price target on shares of Varian Medical Systems in a research note on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price target on shares of Varian Medical Systems in a research note on Monday, August 28th. Zacks Investment Research cut shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Finally, BTIG Research cut shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Thursday, September 7th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. Varian Medical Systems presently has a consensus rating of “Hold” and an average price target of $94.94.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1


Leave a Reply

 
© 2006-2017 BBNS.